Pattern Pharma

Biotechnology Research • Toronto, Ontario, Canada • 1-10 Employees

Company overview

Headquarters	Toronto, Ontario, Canada
Phone number	+14163025155
Website	patternpharma.com
NAICS	541714
Employees	1-10
Socials

Key Contact at Pattern Pharma

Yann Rioux

Director Of Operations

Pattern Pharma Email Formats

Pattern Pharma uses 2 email formats. The most common is {first initial}{first3}{last name} (e.g., j{first3}doe@patternpharma.com), used 50% of the time.

Format	Example	Percentage
{first initial}{first3}{last name}	j{first3}doe@patternpharma.com	50%
{first name}{last name}	johndoe@patternpharma.com	50%

About Pattern Pharma

Pattern’s PPI-100 therapeutic mobilizes innate immunity to address the immune failures underpinning cancers & infectious diseases. Pattern is developing PPI-100 for a range of oncology applications and intends to file a submission in Q4 2025 to commence a clinical study. The first indication is perioperative immunotherapy, which represents a large, white-space opportunity to address the ~40% relapse rate in cancer patients within 5 years after surgery; PPI-100's use in this indication is underpinned by extensive in vivo nonclinical data as well as supporting clinical data. PPI-100 is a significantly improved & patented 2nd generation of an earlier product developed by Pattern Principals that received regulatory approval in ex-US jurisdictions for use against infectious diseases, where it proved safe & efficacious in patients during widespread use. Pattern collaborates with Massachusetts General Hospital, MD Anderson, the University of Toronto, McGill University & others.

Pattern Pharma revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding